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Monilethrix, a rare human hair disorder with
autosomal dominant transmission, can be caused by
mutations in hair keratins. Up to now, causative
mutations have only been found in two type II cortex
keratins, hHb6 and hHb1. In these hair keratins, the
helix termination motif, HTM, was the only site in
which mutations were located. The most frequent
mutation, which has been found in 22 cases, was a
Glu413Lys substitution in hHb6, whereas other
mutations, i.e., hHb6 Glu413Asp, hHb1 Glu413Lys,
and hHb1 Glu402Lys, have been reported in a distinctly
lower number of cases. In this study, we describe the
equivalent of the hHb1 Glu402Lys mutation in the
HTM of cortex keratin hHb6. The mutation occurred
in an American family in which it could only be
detected in one clinically affected individual. Thus the
underlying G→A transition represents a spontaneous
Without a doubt, the most important develop-ment in keratin research in recent years hasbeen the finding that single point mutations inhuman keratin genes, resulting in inappropriateamino acid substitutions in the keratin proteins,
can cause a large number of hereditary pathologies of the epidermis
and its appendages, as well as of other stratified epithelia, such as
oral and esophageal mucosa and the cornea (for review, see Steinert,
1995; Fuchs, 1997). These keratin diseases are due to the inability
of the mutated keratin to form stable intermediate filaments, with
its partner keratin of the opposite type, thus leading to cell fragility
and rupture, particularly upon externally applied mechanical stress.
The disease causing mutations are not randomly distributed along
the keratin molecule, but preferentially occur in distinct segments
which have been found to be crucial for correct filament assembly.
Thus, most of the pathogenic keratin mutations described so far
are clustered in the short and highly conserved segments at the
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germ-line mutation in the hHb6 gene. This new
mutation indicates that both the hHb6/hHb1 Glu413-
Lys substitution and the hHb6/hHb1 Glu402Lys substi-
tution, represent mutational hotspots in the HTM of
type II cortex keratins. However, we also describe a
monilethrix-causing mutation in the helix initiation
motif, HIM, of the cortex keratin hHb6. The critical
Asn114Asp substitution was only found in affected
members of a large Swedish three-generation family.
Considering that since childhood, half of the affected
individuals suffer from complete baldness and follicular
keratosis, the new HIM mutation seems to be associ-
ated with a rather severe disease phenotype. In conclu-
sion, our data strongly suggest that monilethrix is a
disease of the hair cortex, whose etiology is interesting
in that causative mutations seem to be restricted to
type II hair keratins. Key words: hair disease/human/
keratin/point mutation. J Invest Dermatol 113:263–266, 1999
beginning and the end of the central rod domain, termed helix
initiation motif, HIM, and helix termination motif, HTM (for
review, see Steinert, 1995; Corden and McLean, 1996; Fuchs, 1997).
Besides the epithelial or soft α-keratins, the keratin multigene
family also comprises the hard α-keratins which are involved in
the formation of hard keratinized structures, i.e., hair, nail, hoof,
etc. There is evidence that the human hard α- or hair keratin
family is as complex as the epithelial keratin family with the
individual members being differentially expressed in the matrix,
the cuticle, and the cortex of the hair (Rogers et al, 1997, 1998;
unpublished data). We have recently shown that mutations in hair
keratins can also cause hereditary hair diseases. The disorder in
question was monilethrix (Winter et al, 1997a, b, 1998), a pathology
with autosomal dominant transmission which is characterized by
more or less beaded and fragile hairs. Moniliform hair tend to
break at the narrow constrictions thus leading to short, stubby hair,
often associated with follicular hyperkeratosis and perifollicular
erythema. In the milder form, the disease involves only the occipital
regions and the nape of the neck, but in its more severe form,
the entire scalp, secondary sexual hair, eyebrows, eyelashes, and,
occasionally, nails may also be affected (for review, see
Zimmermann, 1983).
In accordance with the previous genetic linkage of three moni-
lethrix pedigrees to the type II hair and epithelial keratin gene
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cluster at 12q13 (Healy et al, 1995; Stevens et al, 1996),1 we were
able to show that affected individuals of two unrelated families
harbored a nonconservative lysine substitution of a glutamic acid
residue, Glu413 (Glu117 of the 2B subdomain) in the HTM of
the type II hair keratin hHb6 which was caused by a GAG→AAG
point mutation in the hHb6 gene (Winter et al, 1997a, b). This
keratin gene is expressed in the hair cortex and among the currently
known type II cortex keratins (hHb1, hHb3, hHb5, hHb6, hHb7),
hHb6 represents the latest expressed hair keratin (Rogers et al,
1997, 1998; and unpublished data). To date, 18 families and four
single patients from different countries have been found to carry
this mutation (Winter et al, 1997a, b; Korge et al, 1998; Zlotogorski
et al, 1998).2 Both a Canadian and an unrelated Irish monilethrix
family exhibited the Glu413Lys mutation, so predominant in the
late hHb6 cortex keratin, in the earlier expressed type II cortex
keratin hHb1 (Winter et al, 1997b).2 Because also in this case, the
lysine substitution was caused by a G→A point mutation in the
first position of the GAG Glu413 codon, this site seems to be a
mutational hotspot in type II cortex keratins. In contrast, in two
other monilethrix families, the hHb6 Glu413 residue was substituted
by a similar acidic aspartic acid residue (Winter et al, 1997a).3
Recently, however, we again discovered a lysine substitution of a
glutamic acid residue in another French family. This mutation
occurred at glutamic acid residue 402 (Glu106 of the 2B subdomain)
of the HTM of cortex keratin hHb1 and was also caused by G→A
point mutation in the corresponding gene (Winter et al, 1998).
[For discrepancies in the numbering of the mutation sites in hair
keratins hHb6 and hHb1 in previous papers (Winter et al, 1997a,b),
see corrections in Winter et al, 1998. Four additional families
carrying this mutation have recently been described by Korge et al
(1999) in footnote 2.] All in all, these data clearly indicate that
monilethrix is a disease of the hair cortex. In the current study we
have analyzed two new monilethrix families in which the disease
is caused by hitherto unknown hair keratin mutations.
MATERIALS AND METHODS
Clinical features of the two families The pedigree of an American
family (family 1) is shown in Fig 1. This family is unusual in that clinically
only one individual, II-1, clearly exhibits a rather severe monilethrix
phenotype. The 24 y old patient had normal scalp hair at birth, but by the
age of 2 y, his hair became abnormally sparse and fragile. At present,
beaded hairs and follicular hyperkeratosis are easily seen with the naked
eye. His body hair and his axillary, but not pubic hair, is also affected. His
nails are fragile and split easily. The pedigree of a three-generation Swedish
family (family 2) is also shown in Fig 1. A general feature in this family is
that all affected members suffered from pronounced hair loss within the
first 2 y of life. Later, in particular after puberty, individuals I-1, II-2, II-
4, and II-6 developed sparse and fragile hair whose beaded structure is
clearly visible with the naked eye. In contrast, individuals II-1, II-7, and
III-1 remained almost bald and still exhibit follicular hyperkeratosis and
perifollicular erythema. In all cases, however, eyebrows and eyelashes are
clinically unremarkable and also nails appear normal.
Mutation analysis After Ethic Committee Approval, blood was drawn
from consenting affected and unaffected members of the two families.
Genomic DNA was isolated from the blood samples as described (Winter
et al, 1997a,b). The gene segments coding for HTM of cortex keratins
hHb1, hHb3, and hHb6 were amplified by the polymerase chain reaction
under conditions described previously, using the primer pairs published in
Winter et al (1997a). The primer pairs used for the amplification of the
gene segments encoding the HIM of hHb1 and hHb3 were also those
described in Winter et al (1997a). In contrast, a new primer pair was used
1Korge B, Richards G, Puenter C, et al: Monilethrix links to the keratin
type II cluster at 12q13 and cloning of a possible candidate gene. J Invest
Dermatol 106:843, 1996 (Abstr.)
2Korge BP, Hamm H, Traupe H, et al: Recurrent point mutations in
human type II hair keratins hHb1 and hHb6. Arch Dermatol Res 291:122,
1999 (Abstr.)
3Oetting WS, Fryer JP, Wyman Z, et al: A mutation in the hHb6 gene
causing monilethrix in an extended Palestinian family from Israel. Am J
Hum Genet 63:A377, 1998 (Abstr.)
Figure 1. Pedigrees of monilethrix families 1 and 2 analyzed in
this study. Clinically affected individuals are shown by solid symbols,
unaffected members by open symbols. Individuals from whom DNA was
obtained are indicated by an asterisk.
for the amplification of the gene segment coding for the HIM of
hHb6 [59-TAATTGCTCCGACCCACGTGGTCAC-39 (forward
primer); 59-CCTTAGTGCCCGG CCCTGGCTGTGT-39 (reverse
primer)]. Polymerase chain reaction products were separated by agarose
gel electrophoresis, purified using silica gel beads (Boehringer, Mannheim,
Germany) and sequenced directly according to the Thermo Sequenase
radiolabeled chain terminator cycle sequencing protocol (Amersham,
Braunschweig, Germany). The HTM product of hHb6 was sequenced
using the reverse polymerase chain reaction primer as sequencing primer;
sequencing of the HIM product of hHb6 was performed with primer 59-
CGAGAGCCTCCTCACGC-39.
RESULTS
A new mutation in the HTM of hHb6 is present in family
1 Based on the predominant involvement of HTM mutations in
type II cortex keratins in the manifestation of monilethrix, we used
a battery of primer pairs tailored for the specific amplification of
the HTM coding regions of cortex keratins hHb1, hHb3, and
hHb6 of patient II-1 of family 1. Direct sequencing of the
amplification products did not reveal deviations from the published
hHb1 and hHb3 sequences (Bowden et al, 1998; Rogers et al,
1997). In contrast, sequencing of the hHb6 derived fragment, led
to the detection of a new heterozygous G→A point mutation in
the first position of the GAG codon coding for Glu402, which
was substituted by a lysine residue (Fig 2). This hHb6 Glu402Lys
mutation in patient II-1 was not found in any of the unaffected
family 1 members and was also absent in 50 unrelated healthy
control individuals (results not shown).
Family 2 exhibits the first mutation in the HIM of
hHb6 Surprisingly, the application of this mutation detection
strategy in affected members of the Swedish family 2, completely
failed to reveal point mutations in the HTM coding region of
hHb1 and hHb6. Likewise, the analysis of the polymerase chain
reaction amplified HTM coding region of the third type II cortex
keratin hHb3, whose gene shares an absolutely identical α-helical
2B subdomain coding region with hHb1 and hHb6 (Rogers et al,
1997; unpublished data), did not reveal any sequence abnormalities
(results not shown). Only when we analyzed the gene regions
coding for the hitherto mutation free HIMs of the three type II
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Figure 2. Mutation analyses of the type II hair keratin gene hHb6. (A) Representative excerpts from DNA sequencing gels showing sequences
coding for part of the HTM (family 1) and the HIM (family 2) of hHb6. The sequences were derived either from unaffected individuals (II-2, family 1;
II-3, family 2) or monilethrix patients (II-1, family 1; II-1, family 2). Numerals refer to the pedigrees in Fig 1. The affected individual II-1 of family 1
is heterozygous for a G→A point mutation (arrowhead); the affected individual II-1 of family 2 is heterozygous for a A→G point mutation (arrowhead). In
this individual, we detected a further heterozygous A→G point mutation (arrow) which was absent from the unaffected individual II-3. (B) DNA and
protein sequences of parts of the HTM and HIM of hHb6. The numbering of the protein sequences was deduced from the amino acid translation of the
hHb6 gene (Bowden et al, 1998). Nucleotide and amino acid substitutions being causative for monilethrix in the two families are given in bold, italic
letters. The asterisk above the third base of the Arg116 codon of the hHb6 HIM sequence of the affected individual II-1 of family 2 indicates the site of
the heterozygous A→G point mutation (arrow in A) which does, however, not entail an amino acid substitution. This polymorphic site was also found
in individuals I-2, II-2, and II-6 of the pedigree.
Table I. Current mutation spectrum of monilethrix. Brackets in column 2 indicate the position of the mutations in the a-
helical 2B and 1A subdomains of type II hair keratins hHb1 and hHb6
No. of case Mutation Type II hair keratin α-Helical subdomain Reference
22 E413K (E117K) hHb6 2B Winter et al, 1997a,b, and unpublished resultsa;
Zlotogorski et al, 1998; Korge et al, 1998, 1999b
2 E413D (E117D) hHb6 2B Winter et al, 1997a; Oetting et al 1998c
2 E413K (E117K) hHb1 2B Winter et al, 1997b; Korge et al, 1999b
5 E402K E106K) hHb1 2B Winter et al, 1998; Korge et al, 1999b
1 E402K (E106K) hHb6 2B This paper
1 N114D (N8D) hHb6 1A This paper
aThe unpublished E413K mutations occurred in a South African family, provided by Dr Donald Basel, Department of Human Genetics, University of Cape Town, and in
a French family, provided by Dr Pierre Vabres, Groupe Hospitalier Necker–Enfants Malades, Paris.
bSee footnote 2.
cSee footnote 3.
cortex keratins of affected individuals, could we demonstrate an
AAC→GAC point mutation which led to an Asn114Asp substitu-
tion (Asn8 of the 1A subdomain) in the cortex keratin hHb6
(Fig 2). Again, this mutation was absent from unaffected members
of the family as well as from 50 unrelated and healthy control
individuals. Apart from the A-G point mutation in the hHb6 gene
causing the Asn114Asp substitution, we detected another A–G
point mutation in individual II-1. This mutation occurred at the
third base of triplet AGA coding for hHb6 Arg116, without,
however, entailing an amino acid substitution (Fig 2). This point
mutation could also be detected in one allele of affected individuals
II-2 and II-6 as well as in the unaffected individual I-2 of family
2, but was virtually absent from any of the unrelated control
individuals. Hence, the observed mutation seems to be a rare
polymorphism.
DISCUSSION
In this study we describe a novel Glu→Lys mutation in the HTM
of the type II cortex keratin hHb6 which was caused by a G→A
point mutation in the first position of the GAG codon of Glu402
in the hHb6 gene of a monilethrix patient of an American family.
The same type of mutation has previously been found in the type
II cortex keratin hHb1 of affected members of five unrelated
monilethrix family (Winter et al, 1998).2 Thus it appears that,
similar to the first base of the GAG codon of Glu413, also the
corresponding position in the GAG codon of Glu402, represents
a highly mutation-sensitive site in type II cortex keratins. In both
cases, the observed G→A base change might be promoted by the
deamination of a methylated CpG element in the anti-sense strand
of the hHb1 and hHb6 genes (Fig 2; Winter et al, 1997a,b, 1998).
Interestingly, at first glance, a French family carrying the hHb1
Glu402Lys mutation, resembled the present family, in that clinically,
only one member showed a rather severe disease phenotype (Winter
et al, 1998). Analysis of the remaining members of the French
family clearly showed that two further individuals (i.e., the younger
brother and the mother of the propositus) carried the hHb1
Glu402Lys mutation, however, although moniliform hair in these
individuals could only be demonstrated by electron microscopic
examination. In the case of the mother, the moniliform hair
phenotype was virtually confined to archival hair that had been
removed during childhood and since then, kept in a locket (Winter
et al, 1998). In contrast, further examination of the present family
1, failed to detect the hHb6 Glu402Lys mutation in any other
family member, thus implying that the mutation in individual II-
1 represents a spontaneous germ-line mutation. All in all, however,
the new hHb6 Glu402Lys mutation brings the number of known
monilethrix families exhibiting causative mutations in the HTM of
type II cortex keratins to 32 (Table I).
In contrast, the Swedish family represents the first one, in which
the causative monilethrix mutation Asn114Asp is located in the
HIM of a cortex keratin. Similar to Glu402 and Glu413 in the
HTM, the HIM Asn114 residue of type II cortex keratins, belongs
to those amino acid residues which are invariably conserved in all
type I and II hair and epithelial keratins (Bowden et al, 1998;
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Hatzfeld and Weber, 1991; Steinert, 1995; Rogers et al, 1997, 1998).
Moreover, several disease causing substitutions of the equivalent of
the hHb6 Asn114 residue have previously been described for
epidermal type I keratin 9 and 10 and epidermal type II keratin 1.
The Asn8 residue in the HIM of keratins seems to be particularly
important for stable filament assembly, as its substitution by
hydroxyl-amino acids (Ser, Tyr), basic amino acids (His, Lys) (see
Steinert, 1995), and, in the present case, acidic amino acids,
invariably entails a disease phenotype. This is confirmed by studies
with synthetic HIM peptides which have shown that unlike the
wild-type HIM, peptides bearing His, Gln or, more importantly,
Asp substitutions of Asn 8, exhibit a strongly reduced capacity to
disassemble preformed keratin intermediate filaments in vitro
(Steinert et al, 1993).
Whereas the Asn114Asp substitution represents the first moni-
lethrix causing mutation that is not located in the preferentially
mutated HTM of cortex keratins, it still occurs in a type II hair
keratin and thus brings the number of type II hair keratin mutated
monilethrix families to 33 (Table I). In contrast, monilethrix
families with causative mutations in type I hair keratins have not
yet been found and genetic linkage analyses have not identified
families in which the disease maps to the type I hair locus at
17q12–q21 (Richard et al, 1996; own unpublished results). This
striking restriction of causative mutations to type II hair keratins is
intriguing because, for most other keratin diseases, the rate of
pathogenic mutations is about equal in both type I and II keratins
(Steinert, 1995; Fuchs, 1997). In vitro association studies of recom-
binant human type I and type II hair keratins have recently shown
that the assembly conditions for hair keratins are distinctly different
from those for epithelial keratins as they required salt concentrations
usually necessary for the monomeric assembly of vimentin (Winter
et al, 1997c; and unpublished data). Whether this means that in
the assembly process of hair keratins, type II hair keratins play a
more important part than type I hair keratins, and thus, mutations
in the latter remain without visible phenotypic consequences,
awaits to be seen.
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